Revisiting the escherichia coli polysaccharide capsule as a virulence factor during urinary tract infection, Contribution to intracellular biofilm development

Virulence

Volumn 1, Issue 4, 2010, Pages 333-337

  Goller, Carlos C ^a   Seed, Patrick C ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biofilm; Capsule; Escherichia coli; IBC; Intracellularbacterial communities; Polysaccharide; Sialic acid; Urinary tract infection; Virulence

Indexed keywords

POLYSACCHARIDE; SIALIC ACID;

ARTICLE; BIOFILM; BLADDER EPITHELIUM; CELL PROLIFERATION; CYTOSOL; ESCHERICHIA COLI; HOMEOSTASIS; HOST CELL; IMMUNOSURVEILLANCE; INTRACELLULAR BACTERIUM; MICROBIAL COMMUNITY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOGENESIS; URINARY TRACT INFECTION;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 77954983629     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284:1318-22.
2. del Pozo JL, Patel R. The challenge of treating biofilm-associated bacterial infections. Clin Pharmacol Ther 2007; 82:204-9.
3. Dongari-Bagtzoglou A. Pathogenesis of mucosal biofilm infections: challenges and progress. Expert Rev Anti Infect Ther 2008; 6:201-8.
4. Anderson GG, O'Toole GA. Innate and induced resistance mechanisms of bacterial biofilms. Curr Top Microbiol Immunol 2008; 322:85-105.
5. Haussler S, Parsek MR. Biofilms 2009; New perspectives at the heart of surface-associated microbial communities. J Bacteriol JB.00332-10.
6. Goller CC, Romeo T. Environmental influences on biofilm development. Curr Top Microbiol Immunol 2008; 322:37-66.
7. Anderson GG, Palermo JJ, Schilling JD, Roth R, Heuser J, Hultgren SJ. Intracellular bacterial biofilmlike pods in urinary tract infections. Science 2003; 301:105-7.
8. Rosen DA, Hooton TM, Stamm WE, Humphrey PA, Hultgren SJ. Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med 2007; 4:329.
9. Justice SS, Hunstad DA, Seed PC, Hultgren SJ. Filamentation by Escherichia coli subverts innate defenses during urinary tract infection. Proc Natl Acad Sci USA 2006; 103:19884-9.
10. Justice SS, Lauer SR, Hultgren SJ, Hunstad DA. Maturation of intracellular Escherichia coli communities requires SurA. Infect Immun 2006; 74:4793-800.
11. Wright KJ, Seed PC, Hultgren SJ. Development of intracellular bacterial communities of uropathogenic Escherichia coli depends on type 1 pili. Cell Microbiol 2007; 9:2230-41.
12. Justice SS, Hung C, Theriot JA, Fletcher DA, Anderson GG, Footer MJ, et al. Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc Natl Acad Sci USA 2004; 101:1333-8.
13. Blango MG, Mulvey MA. Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrob Agents Chemother 2010; 54:1855-63.
14. Itoh Y, Wang X, Hinnebusch BJ, Preston JF, 3rd, Romeo T. Depolymerization of beta-1,6-N-acetyl-Dglucosamine disrupts the integrity of diverse bacterial biofilms. J Bacteriol 2005; 187:382-7.
15. Wang X, Preston JF, 3rd, Romeo T. The pgaABCD locus of Escherichia coli promotes the synthesis of a polysaccharide adhesin required for biofilm formation. J Bacteriol 2004; 186:2724-34.
16. Choi AH, Slamti L, Avci FY, Pier GB, Maira-Litran T. The pgaABCD locus of Acinetobacter baumannii encodes the production of poly-beta-1-6-N-acetylglucosamine, which is critical for biofilm formation. J Bacteriol 2009; 191:5953-63.
17. Gotz F. Staphylococcus and biofilms. Mol Microbiol 2002; 43:1367-78.
18. Whitfield C, Keenleyside WJ. Regulation of expression of group IA capsular polysaccharides in Escherichia coli and related extracellular polysaccharides in other bacteria. J Ind Microbiol 1995; 15:361-71.
19. Danese PN, Pratt LA, Kolter R. Exopolysaccharide production is required for development of Escherichia coli K-12 biofilm architecture. J Bacteriol 2000; 182:3593-6.
20. Roberts IS. Bacterial polysaccharides in sickness and in health. The 1995 Fleming Lecture. Microbiology 1995; 141:2023-31.
21. Roberts IS. The biochemistry and genetics of capsular polysaccharide production in bacteria. Annu Rev Microbiol 1996; 50:285-315.
22. Llobet E, Tomas JM, Bengoechea JA. Capsule polysaccharide is a bacterial decoy for antimicrobial peptides. Microbiology 2008; 154:3877-86.
23. Johnson JR. Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 1991; 4:80-128.
24. Whitfield C. Biosynthesis and assembly of capsular polysaccharides in Escherichia coli. Annu Rev Biochem 2006; 75:39-68.
25. Whitfield C, Roberts IS. Structure, assembly and regulation of expression of capsules in Escherichia coli. Mol Microbiol 1999; 31:1307-19.
26. Anderson GG, Goller CC, Justice S, Hultgren SJ, Seed PC. Polysaccharide capsule and sialic acidmediated regulation promote biofilm-like intracellular bacterial communities during cystitis. Infect Immun 2010; 78:963-75.
27. Haraoka M, Hang L, Frendeus B, Godaly G, Burdick M, Strieter R, et al. Neutrophil recruitment and resistance to urinary tract infection. J Infect Dis 1999; 180:1220-9.
28. Rosen DA, Pinkner JS, Jones JM, Walker JN, Clegg S, Hultgren SJ. Utilization of an intracellular bacterial community pathway in Klebsiella pneumoniae urinary tract infection and the effects of FimK on type 1 pilus expression. Infect Immun 2008; 76:3337-45.
29. Bokranz W, Wang X, Tschape H, Romling U. Expression of cellulose and curli fimbriae by Escherichia coli isolated from the gastrointestinal tract. J Med Microbiol 2005; 54:1171-82.
30. Gening ML, Maira-Litran T, Kropec A, Skurnik D, Grout M, Tsvetkov YE, et al. Synthetic {beta}-(1->6)-linked N-acetylated and nonacetylated oligoglucosamines used to produce conjugate vaccines for bacterial pathogens. Infect Immun 78:764-72.